CVS HEALTHCVS
紐約證券 · USD
62.10
-0.20
(-0.32%)
收盤 08/01 03:59 (UTC+8)
盤後
62.11
+0.01
(+0.02%)
08/01 03:59 (UTC+8)
CVS HEALTHCVS
62.10
-0.20
(-0.32%)
財務數據
損益表
- 852.78
- 889.21
- 897.64
- 938.13
- 884.37
- 912.34
- 954.28
- 977.10
- 945.88
- 989.15
- 1.71
- 4.27
- 0.95
- 4.51
- -5.73
- 3.16
- 4.60
- 2.39
- -3.20
- 4.57
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 98,915,000 | 94,588,000 | 97,710,000 | 95,428,000 | 91,234,000 | 88,437,000 | 93,813,000 | 89,764,000 | 88,921,000 | 85,278,000 |
營業成本 | - | 51,057,000 | 55,268,000 | 52,948,000 | 49,998,000 | 48,073,000 | 57,419,000 | 54,688,000 | 53,536,000 | 71,903,000 |
營業毛利 | - | 43,531,000 | 42,442,000 | 42,480,000 | 41,236,000 | 40,364,000 | 36,394,000 | 35,076,000 | 35,385,000 | 13,375,000 |
營業費用 | - | - | - | - | - | - | 33,021,000 | 31,386,000 | 32,151,000 | 9,580,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | - | 40,157,000 | 39,964,000 | 40,479,000 | 38,191,000 | 38,093,000 | 33,021,000 | 31,375,000 | 31,655,000 | 9,580,000 |
非經常性項目費用 | - | - | 110,000 | 1,169,000 | - | - | - | 11,000 | 496,000 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 2,381,000 | 3,374,000 | 2,368,000 | 832,000 | 3,045,000 | 2,271,000 | 3,373,000 | 3,690,000 | 3,234,000 | 3,446,000 |
其他收入及費用 | - | 28,000 | 516,000 | 25,000 | 24,000 | 25,000 | 22,000 | 22,000 | 22,000 | -327,000 |
利息費用 | - | 785,000 | 758,000 | 752,000 | 732,000 | 716,000 | 690,000 | 693,000 | 686,000 | 589,000 |
稅前純益 | 1,647,000 | 2,617,000 | 2,126,000 | 105,000 | 2,337,000 | 1,580,000 | 2,705,000 | 3,019,000 | 2,570,000 | 2,879,000 |
所得稅 | 634,000 | 835,000 | 503,000 | 34,000 | 569,000 | 456,000 | 658,000 | 754,000 | 656,000 | 737,000 |
稅後純益 | 1,021,000 | 1,779,000 | 1,644,000 | 87,000 | 1,770,000 | 1,113,000 | 2,046,000 | 2,261,000 | 1,901,000 | 2,136,000 |
基本每股稅後盈餘(元) | 0.81 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 | 1.48 | 1.66 |
稀釋每股稅後盈餘(元) | 0.80 | 1.41 | 1.31 | 0.07 | 1.40 | 0.88 | 1.59 | 1.75 | 1.48 | 1.65 |
基本平均股數(千股) | 1266000.00 | 1261000.00 | 1259000.00 | 1259000.00 | 1256000.00 | 1260000.00 | 1288000.00 | 1287000.00 | 1283000.00 | 1283000.00 |
稀釋平均股數(千股) | 1270000.00 | 1264000.00 | 1261000.00 | 1259000.00 | 1259000.00 | 1267000.00 | 1293000.00 | 1290000.00 | 1287000.00 | 1291000.00 |
還原基本每股稅後盈餘(元) | 0.81 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 | 1.48 | 1.66 |
還原稀釋每股稅後盈餘(元) | 0.80 | 1.41 | 1.31 | 0.07 | 1.40 | 0.88 | 1.59 | 1.75 | 1.48 | 1.65 |
還原基本平均股數(千股) | 1,266,000 | 1,261,000 | 1,259,000 | 1,259,000 | 1,256,000 | 1,260,000 | 1,288,000 | 1,287,000 | 1,283,000 | 1,283,000 |
還原稀釋平均股數(千股) | 1,270,000 | 1,264,000 | 1,261,000 | 1,259,000 | 1,259,000 | 1,267,000 | 1,293,000 | 1,290,000 | 1,287,000 | 1,291,000 |
EBITDA(千元) | 1,655,000 | 4,553,000 | 4,052,000 | 2,034,000 | 4,222,000 | 3,423,000 | 4,528,000 | 4,835,000 | 4,347,000 | 4,463,000 |